Heron Therapeutics Inc - ESG Rating & Company Profile powered by AI
The ESG score covers seventeen United Nations SDGs including: 'No Poverty', 'Decent Work & Economic Growth' and 'Life below Water'. This analysis of Heron Therapeutics Inc leverages intelligence from across the web and also from available documents by Heron Therapeutics Inc. Alternative corporations in the rating industry group for Heron Therapeutics Inc are displayed.
Heron Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 4.8, social score of 4.8 and governance score of 6.7.
5.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 835 | Wuhan Keqian Biology Co Ltd | 5.5 | High |
| 835 | dorsaVi Ltd | 5.5 | High |
| 886 | Heron Therapeutics Inc | 5.4 | High |
| 886 | Avant Brands Inc | 5.4 | High |
| 886 | Antengene Corporation Ltd | 5.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Heron Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Heron Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Heron Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Heron Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Heron Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Heron Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Heron Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Heron Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Heron Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Heron Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Heron Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Heron Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Heron Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Heron Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Heron Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Heron Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Heron Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Heron Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam, which is in Phase III clinical trials for pain management; and HTX-034, which is in Phase Ib/II clinical trials for postoperative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.